- Home
- FFIN vs VKTX Comparison
FFIN vs VKTX Comparison
Compare FFIN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIN | VKTX |
|---|---|---|
| Founded | 1890 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.4B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FFIN | VKTX |
|---|---|---|
| Price | $35.25 | $37.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $36.50 | ★ $95.86 |
| AVG Volume (30 Days) | 896.0K | ★ 3.0M |
| Earning Date | 04-16-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | ★ 13.46 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | $72.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.12 | $22.96 |
| 52 Week High | $38.13 | $43.15 |
Technical Indicators
Market Signals| Indicator | FFIN | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 52.98 |
| Support Level | $31.30 | $32.66 |
| Resistance Level | $35.77 | $39.78 |
| Average True Range (ATR) | 0.76 | 2.30 |
| MACD | 0.04 | -0.44 |
| Stochastic Oscillator | 49.62 | 23.27 |
Price Performance
Historical ComparisonAbout FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.